Nanospectra Biosciences
Pre-clinicalNanospectra Biosciences is a medical device company pioneering a patient-centric use of nanomedicine for selective thermal ablation.
Founded
2002
Focus
OncologyDrug Delivery
About
Nanospectra Biosciences is a medical device company pioneering a patient-centric use of nanomedicine for selective thermal ablation.
Funding History
3Total raised: $24.5M
Series B$17MUndisclosedOct 15, 2022
Grant$2MNational Cancer InstituteMar 15, 2021
Series A$5.5MUndisclosedJun 15, 2019
Company Info
TypePrivate
Founded2002
LocationHouston, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile